| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |